4D Molecular Therapeutics
FDMT
FDMT
96 hedge funds and large institutions have $622M invested in 4D Molecular Therapeutics in 2022 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 25 increasing their positions, 33 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
1.54% more ownership
Funds ownership: 84.9% → 86.45% (+1.5%)
24% less repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 33
Holders
96
Holding in Top 10
2
Calls
$2.74M
Puts
$981K
Top Buyers
| 1 | +$17.2M | |
| 2 | +$14M | |
| 3 | +$13.3M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$12.4M |
| 5 |
Norges Bank
Oslo,
Norway
|
+$6.53M |
Top Sellers
| 1 | -$26.1M | |
| 2 | -$12.5M | |
| 3 | -$12.2M | |
| 4 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$12M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$5.8M |